Xiang Zhou

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center, Zoucheng People's Hospital, National Clinical Research · ORCID：0000-0003-0935-8175

发表论文 30 篇 · 总被引 411 次 · h-index 11

代表论文

• Efficacy and safety of lenvatinib plus PD-1 inhibitor with or without transarterial chemoembolization in unresectable hepatocellular carcinoma (2023 · Hepatology International · 被引 60)
• The Effect of Acupuncture on Chemotherapy-Associated Gastrointestinal Symptoms in Gastric Cancer (2017 · Current Oncology · 被引 53)
• Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (2022 · Frontiers in Immunology · 被引 51)
• Thromboembolic events in Janus kinase inhibitors: A pharmacovigilance study from 2012 to 2021 based on the Food and Drug Administration's Adverse Event Reporting System (2022 · British Journal of Clinical Pharmacology · 被引 36)
• Can the Contrast-Enhanced Ultrasound Washout Rate Be Used to Predict Microvascular Invasion in Hepatocellular Carcinoma? (2017 · Ultrasound in Medicine & Biology · 被引 30)
• The Role of 18F-FDG PET/CT in the Evaluation of Peritoneal Thickening of Undetermined Origin (2016 · Medicine · 被引 24)